Find a Research Expert

Experts
 Menu

Isabella Bray

Institution

Royal College of Surgeons in Ireland

Contact

Subjects

Biochemistry

Details
Publications 35
As first author 4
As last author 6
Unique topics 263
Collaborations 37
Patents 1
Sources 5
Are you Isabella Bray? Click here to provide feedback on your profile.
All
2017
2016
2015
2014
2013
2012
2011
2010
2009
Earlier
All
2017
2016
2015
2014
2013
2012
2011
2010
2009
Earlier

2017

A physiologically relevant 3D collagen-based scaffold-neuroblastoma cell system exhibits chemosensitivity similar to orthotopic xenograft models.
2016

Endoplasmic reticulum stress-mediated upregulation of miR-29a enhances sensitivity to neuronal apoptosis.
2015

ER Stress-Mediated Upregulation of miR-29a Enhances Sensitivity to Neuronal Apoptosis.
2015

MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes.
2015

The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro.
2014

Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy.
2013

Discovery and visualization of miRNA-mRNA functional modules within integrated data using bicluster analysis.
2013

Metastasis suppressor microRNA-335 targets the formin family of actin nucleators.
2013

MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1.
2013

Modulation of chemotherapeutic drug resistance in neuroblastoma SK-N-AS cells by the neural apoptosis inhibitory protein and miR-520f.
2013

The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.
2012

Expression profiling the microRNA response to epileptic preconditioning identifies miR-184 as a modulator of seizure-induced neuronal death.
2012

Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles.
2012

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome.
2012

MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1.
2012

Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs.
2012

Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis.
2012

The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.
2011

MicroRNA and DNA methylation alterations mediating retinoic acid induced neuroblastoma cell differentiation.
2011

MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2.
2011

Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis.
2011

miRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132.
2010

Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastoma.
2010

MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2.
2010

MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma.
2010

Therapeutic targeting of miRNAs in neuroblastoma.
2010

miR-126 Is Downregulated in Cystic Fibrosis Airway Epithelial Cells and Regulates TOM1 Expression.
2010

miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression.
2009

Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylation.
2009

Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylation.
2009

MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2.
2009

Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival.
2009

Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival.
2006

Effects of overexpression of eIF4E and erbB2 on gene expression proflies and invasive phenotype in human cancer cells.
2006

RNA Interference with siRNA.

These arethe5 unique sources for Isabella Bray's 35 publications. A single publication may appear in multiple sources. Click on a name or publication count to see the publications for a particular source.

Source #
Ireland -> Dublin City University 3
Ireland -> Dublin City University -> PubMed 2
Ireland -> Royal College of Surgeons in Ireland 32
Ireland -> Royal College of Surgeons in Ireland -> PubMed 24
Ireland -> Trinity College Dublin 1
Jan 29, 2009

MARKERS FOR INVASION IN BREAST AND LUNG CARCINOMA
+

  1. Further insights

    Clicking through these tabs will give you a wealth of further insights into this expert through their commonly used topics, the evolution of their expertise, their collaborators and their publications.

  2. Details

    Here is a quick breakdown of this expert's publication history

  3. Contact

    If this is the expert you have been looking for, simply click here to make contact.